Xeris Pharmaceuticals Inc reported $-25787000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -9684000 20K
Eli Lilly And LLY:US $ 1428.4M 237.8M
Endo International Ordinary Shares ENDP:US $ 195.54M 19.6M
Horizon Pharma HZNP:US 213.77M 303.22M
JAZZ PHA JAZZ:US -69590000 231.71M
Nektar Therapeutics NKTR:US $ -110205000 813K
Pacira Pharmaceuticals PCRX:US $ 34.99M 13.68M
Perrigo Ordinary Shares PRGO:US $ 44.1M 18.3M
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical Industries TEVA:US 829M 35M
Zogenix ZGNX:US $ -55431000 3.63M